Your browser doesn't support javascript.
loading
Prevalence of hepatitis C virus infection among thalassemia patients: a perspective from a multi-ethnic population of Pakistan.
Din, Ghufranud; Malik, Sajid; Ali, Ihsan; Ahmed, Safia; Dasti, Javid Iqbal.
Afiliación
  • Din G; Department of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
  • Malik S; Human Genetics Program, Department of Animal Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
  • Ali I; Department of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
  • Ahmed S; Department of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
  • Dasti JI; Department of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan. Electronic address: javiddashti@yahoo.com.
Asian Pac J Trop Med ; 7S1: S127-33, 2014 Sep.
Article en En | MEDLINE | ID: mdl-25312106
ABSTRACT

OBJECTIVE:

To evaluate current situation regarding the prevalence of hepatitis C virus (HCV) in thalassemic patients visiting a thalassemia centre in Rawalpindi District, Pakistan for supportive therapy.

METHODS:

Serum samples were screened for hepatitis B surface antigen and anti-HCV by using commercially available ELISA kit. Micro-plate reader was used to perform analysis based on the absorbance/cut-off ratios. Samples were considered positive or negative. Results from ELISA were analyzed statistically.

RESULTS:

A total of 95 subjects were observed to have ß-thalassemia major (96%) and ß-thalassemia intermedia (4%). Among these, 47 (49%) were detected positive for anti-HCV antibodies and three for hepatitis B surface antigen. All recruited subjects were observed for therapy/medication behavior and clinical complications. About 83 (87%) patients were on chelation therapy, and overall complications (hepatomegaly, splenomegaly and splenectomy) were observed in 81% individuals. The distribution of disease status (thalassemia and hepatitis) was not significantly associated with gender, age, origin, province, socio-economic status and parental marriage type (P>0.05). The distributions of ferritin levels, therapy/medication and complications were assessed across demographic variables. Thalassemic subjects were distributed with respect to their sporadic and familial presentations. Among the familial cases (n=35), a total of 93 subjects were found to be affected. Parity was scored for the index cases, and majority belonged to second parity (29%), followed by first and third parities (25% and 15%, respectively). The sibship size was increasing with increasing parity level.

CONCLUSIONS:

Although standardized blood screening procedures are supposed to be implemented, higher prevalence of HCV in thalassemic patients requires greater attention in Pakistan. Furthermore, a poor compliance regarding iron chelation therapy has been observed in this study.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Asian Pac J Trop Med Año: 2014 Tipo del documento: Article País de afiliación: Pakistán

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prevalence_studies / Risk_factors_studies Idioma: En Revista: Asian Pac J Trop Med Año: 2014 Tipo del documento: Article País de afiliación: Pakistán